- Home
- XAIR vs AMS Comparison
XAIR vs AMS Comparison
Compare XAIR & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- AMS
- Stock Information
- Founded
- XAIR 2011
- AMS 1980
- Country
- XAIR United States
- AMS United States
- Employees
- XAIR N/A
- AMS N/A
- Industry
- XAIR Medical/Dental Instruments
- AMS Medical Specialities
- Sector
- XAIR Health Care
- AMS Health Care
- Exchange
- XAIR Nasdaq
- AMS Nasdaq
- Market Cap
- XAIR 17.0M
- AMS 17.2M
- IPO Year
- XAIR N/A
- AMS N/A
- Fundamental
- Price
- XAIR $2.50
- AMS $2.56
- Analyst Decision
- XAIR Strong Buy
- AMS
- Analyst Count
- XAIR 1
- AMS 0
- Target Price
- XAIR $11.00
- AMS N/A
- AVG Volume (30 Days)
- XAIR 466.2K
- AMS 99.6K
- Earning Date
- XAIR 11-10-2025
- AMS 11-12-2025
- Dividend Yield
- XAIR N/A
- AMS N/A
- EPS Growth
- XAIR N/A
- AMS N/A
- EPS
- XAIR N/A
- AMS N/A
- Revenue
- XAIR $4,782,000.00
- AMS $29,251,000.00
- Revenue This Year
- XAIR $263.75
- AMS $5.06
- Revenue Next Year
- XAIR $148.43
- AMS N/A
- P/E Ratio
- XAIR N/A
- AMS N/A
- Revenue Growth
- XAIR 168.20
- AMS 26.61
- 52 Week Low
- XAIR $2.02
- AMS $2.27
- 52 Week High
- XAIR $13.52
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- XAIR 52.02
- AMS 49.43
- Support Level
- XAIR $2.16
- AMS $2.41
- Resistance Level
- XAIR $2.53
- AMS $3.10
- Average True Range (ATR)
- XAIR 0.13
- AMS 0.18
- MACD
- XAIR 0.03
- AMS -0.01
- Stochastic Oscillator
- XAIR 91.89
- AMS 21.83
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.